PRODUCTS & SERVICES
EPCIS TI DATA EXCHANGE
Securely Exchange Standardized Data Requests
Trust.med is enhancing the way the healthcare supply chain tracing data is exchanged, accessed, and communicated between direct trading partners.
Trust.med domain names and URLs activate your supply chain data and messages, giving you the ability to exchange regulated product data and securely communicate with your direct trading partners.
Trust.med domains identify authenticated sources of information for drug products utilizing GTINs. Our resolvers organize your question and return results based on the, industry standard, GS1 Digital Link.
Utilizing the infrastructure of the domain name system (DNS), Trust.med empowers direct trading partners to easily capture and share EPCIS files, enhanced recall communications, and more.
Exchange serialized data with direct trading partners by assigning data access points to GTIN based .med domain names. Direct trading partners can access your data by visiting the "GTIN".med.
DSCSA License Checks for Every Shipment
ATP Verification by Trust.med checks the license status of each trading partner you exchange product ownership with before shipping or data exchange occurs. Every license check is logged & stored for a minimum of 6 years. All activities can easily be exported to customizable reports.
Meet DSCSA compliance, enhance business processes, and improve patient safety with Trust.med's authorized trade partner verification service.
Meet your trading partner verification requirements at the entity or location level with Trust.med and its network of partners. Trust.med is a member of the Open Credentialing Initiative (OCI).
Utilizing both Verifiable Credentials and License Check Services, Trust.med provides the ability to verify the license status of pharmacies, hospitals, and dispensers - giving you the ability to move product within DSCSA guidelines.
Our application programming interface (API) offers seamless integration into your existing shipping process, while our non-technical implementation allows you to meet DSCSA requirements without a single line of code.
Improve Patient Safety
Dispensers of all sizes can now verify drug products with indirect trading partners. Trust.med enables any authorized trade partner to verify drug products through the verification router service (VRS).
Product verification can be done through scanning, inventory management integrations, or directly through the Trust.med registry.
DSCSA requires that pharmacies, hospitals, and manufacturers have the ability to verify and respond to verification requests. The Trust.med registry makes it easy to meet these requirments by using just the GTIN.
Improve patient safety by utilizing our registry of product verification information. Identify the GTIN of a product, visit the "GTIN.med" domain, and verify for a safer drug supply chain.
Trust.med closes the technological gap between dispensers and indirect trading partners. Our technology uses internet standards providing ease of use and accessibility while offering ease of integration into any existing application.
ENHANCED RECALL NOTIFICATIONS
Direct & Indirect Targeted Recall Communication
Drug manufacturers, wholesale distributors, pharmacies, and hospital systems have come together with Trust.med to collaborate on an enhanced recall system that focuses on delivering critical recall information.
Enhanced Recall Notifications by Trust.med streamlines the communication and response mechanisms of the recall process. This environmentally conscious solution produces: increased efficiency, cost savings, and improved patient safety.
Improve the efficiency of recall notifications and acknowledgement reporting with Trust.med. This electronic notification and reporting platform provides more insight and streamlines delivery of notifications to reach beyond the direct consignee.
Reduce cost and waste. Our Enhanced Recall Notification platform delivers your notifications, collects acknowledgements, and provides progress reports digitally - Significantly reducing the use of paper and its associated administrative fees.
Recall Notifications can now be sent to direct consignees, subscribers, and recipients of the product you recall - reducing notification noise, improving awareness, and decreasing acknowledgement response times.
Having successfully completed the first phase of work, Trust.med and industry stakeholders are beginning a second phase of development that will accomplish targeted recall communications, significantly enhancing recalled drug communication with direct and indirect trading partners who have received recalled product.
View the Trust.med Enhanced Recall Notifications first year timeline and learn about our development of a safer, more efficient drug recall system.